Your browser doesn't support javascript.
loading
SARS-CoV-2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs.
van der Donk, Lieve E H; Eder, Julia; van Hamme, John L; Brouwer, Philip J M; Brinkkemper, Mitch; van Nuenen, Ad C; van Gils, Marit J; Sanders, Rogier W; Kootstra, Neeltje A; Bermejo-Jambrina, Marta; Geijtenbeek, Teunis B H.
Afiliação
  • van der Donk LEH; Department of Experimental Immunology, Amsterdam institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Eder J; Department of Experimental Immunology, Amsterdam institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • van Hamme JL; Department of Experimental Immunology, Amsterdam institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Brouwer PJM; Department of Medical Microbiology, Amsterdam institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Brinkkemper M; Department of Medical Microbiology, Amsterdam institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • van Nuenen AC; Department of Experimental Immunology, Amsterdam institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • van Gils MJ; Department of Medical Microbiology, Amsterdam institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Sanders RW; Department of Medical Microbiology, Amsterdam institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Kootstra NA; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA.
  • Bermejo-Jambrina M; Department of Experimental Immunology, Amsterdam institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Geijtenbeek TBH; Department of Experimental Immunology, Amsterdam institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Eur J Immunol ; 52(4): 646-655, 2022 04.
Article em En | MEDLINE | ID: mdl-35099061
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Receptor 4 Toll-Like / Glicoproteína da Espícula de Coronavírus / COVID-19 Limite: Humans Idioma: En Revista: Eur J Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Receptor 4 Toll-Like / Glicoproteína da Espícula de Coronavírus / COVID-19 Limite: Humans Idioma: En Revista: Eur J Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda